首页|固相萃取-HPLC法测定艾地骨化醇软胶囊中有关物质

固相萃取-HPLC法测定艾地骨化醇软胶囊中有关物质

扫码查看
目的:建立一种氨基固相萃取-HPLC法测定艾地骨化醇软胶囊中3个同分异构体的有关物质.方法:采用氨基固相萃取法,经乙酸乙酯-正己烷洗脱,无水乙醇提取,提取液经减压蒸干后用乙腈复溶,经ODS色谱柱(250 mm ×4.6 mm,5 µm)分析,以水-乙腈为流动相,梯度洗脱,流速为1.0 mL·min-1,进样量为50 μL,采用紫外检测器,在检测波长265 nm处检测有关物质.结果:固相萃取前处理可有效去除空白油干扰,艾地骨化醇与各杂质均可基线分离;在低温4 ℃条件下考察溶液稳定性,24 h时供试品溶液中各杂质面积百分比为98.6%~102.3%;杂质对照品溶液中,24 h时Tachy杂质、前体、艾地骨化醇和Trans杂质的面积百分比分别为101.2%、96.9%、98.5%和96.2%;艾地骨化醇、trans杂质、前体和tachy杂质的定量限分别为 0.107、0.102、0.128、0.063 μg·mL-1,检测限分别为 0.054、0.051、0.064、0.031μg·mL-1;四者质量浓度分别在 0.1~6.3 μg·mL-1、0.1~1.2μg·mL-1、0.1~5.6 μg·mL-1 和 0.1~1.1 μg·mL-1范围内与峰面积呈良好线性关系,相关系数(n=5)分别为0.999 9、1.000、1.000和0.999 4;tachy杂质、前体和 trans 杂质回收率(n=6)分别为 106.6%、88.6%和 102.8%,RSD(n=6)分别为 6.7%、3.1%和2.1%.3批样品含前体5.0%、5.0%和5.1%,杂质tachy、杂质Trans和未知单杂均未检出.结论:该方法操作简单,经济实用,安全性高,专属性强,重复性好,准确度高,为艾地骨化醇软胶囊及类似油性基质的药物质量研究提供可靠依据.
Determination of related substances in eldecalcitol soft capsules by solid phase extraction-HPLC
Objective:To establish an amino solid-phase extraction-HPLC method for the determination of three related substances in eldecalcitol soft capsules.Methods:The eldecalcitol soft capsules were extracted by an amino solid-phase extraction method,followed by eluting with ethyl acetate:n-hexane and anhydrous etha-nol.The residue was then dissolved with acetonitrile and water after vacuum evaporation.An ODS column(250 mm×4.6 mm,5 μm)was used.Water-acetonitrile with gradient elution was employed.The flow rate was 1.0 mL·min-1,the injection volume was 50 μL,and the detection wavelength was set at 265 nm.Results:Interference from blank excipients was eliminated with pretreatment.Baseline separation and good selec-tivity of eldecalcitol and other impurities was achieved.The stability of the test and reference solution was investi-gated at 4 ℃.The area change percentage of the impurities in the test solution were 98.6%-102.3%at 24 h.The area change percentage of the impurities in the reference solution were 101.2%,96.9%,98.5%and 96.2%at 24 h,respectively.The quantitation limits of eldecalcitol,trans impurity,pre-eldecalcitol and tachy impurity were 0.107 μg·mL-1,0.102 μg·mL-1,0.128 μg·mL-1 and 0.063 μg·mL-1,respectively.The detection limits were 0.054 μg·mL-1,0.051 μg·mL-1,0.064 μg·mL-1,0.031 μg·mL-1,respectively.The linear ranges of 4 components were 0.1-6.3 μg·mL-,0.1-1.2 μg·mL-,0.1-5.6 μg·mL-and 0.1-1.1 μg·mL-1,respectively.The correlation coefficients(n=5)were 0.999 9,1.000,1.000 and 0.999 4,respectively.The average recoveries(n=6)of tachy impurity,pre-eldecalcitol and trans impurity were 106.6%,88.6%and 102.8%with RSDs of 6.7%,3.1%and 2.1%,respectively.In the three batches of samples,no impurities were detected except pre-eldecalcitol.The contents of pre-eldecalcitol were 5.0%,5.0%and 5.1%,respectively.Conclusion:The method is simple to operate,economical and practical with high safety,strong specificity,good repeatability and high accuracy.The method provides a reliable basis for the study of drug quality such as eldecalcitol soft capsules and drugs with similar oily substrate.

solid-phase extractioneldecalcitol soft capsulesoily substrateactivated vitamin Dstructural isomerrelated substances

李洁、王清亭、张丽敏、张佳鸿、刘振飞、陈阳生

展开 >

正大制药(青岛)有限公司,青岛 266000

固相萃取 艾地骨化醇软胶囊 油性基质 活性维生素D 同分异构体 有关物质

泰山产业领军人才工程资助

tscx202211121

2024

药物分析杂志
中国药学会

药物分析杂志

CSTPCD北大核心
影响因子:1.039
ISSN:0254-1793
年,卷(期):2024.44(6)